$ANGX

Sarowitz Steven I purchased $473K of ANGX

Sarowitz Steven I purchased 88,647 shares of Angel Studios, Inc. (ANGX) at $5.33 ($0.47M total) on 2026-09-11.

Original reporting
SEC EDGAR · Sarowitz Steven I
Published Sep 14, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 9:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ANGX
Bullish
medium confidence
Mentioned
$ANGX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ANGXBullishLow
01

Why it matters

The purchase modestly raises insider ownership, suggesting confidence but unlikely to affect stock price materially.

02

Market read

Small insider buy; limited immediate trading relevance.

03

What to watch

Potential upcoming financing or strategic moves not disclosed.

Relevance 5/10Novelty 4/10Timing: filed 2026-09-14

Background

SEC Form 4 filing discloses insider transactions; director purchases are monitored for signals.

Company-level read

Ticker impact

$ANGXBullishMedium confidence
Context

Director Steven Sarowitz bought 88,647 shares for $473K, increasing his stake to 1.33M shares.

Expected impact

Minor upward pressure, unlikely to move price materially.

Evidence & confidence

Purchase size is modest relative to float; director involvement adds some credibility but not enough for significant price change.

Market effects

None significant for media/entertainment sector.

No regional effect.

Limited to Angel Studios investors.

Counterpoint

Insider buying could be routine portfolio rebalancing, not a strong bullish signal.

Key entities

  • Angel Studios, Inc.

    Media streaming platform listed on NASDAQ under ANGX.

  • Steven Sarowitz

    Director of Angel Studios who made the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ANGXMed

B. Riley Lifts PT on Angel Studios (ANGX) – Here’s Why

B. Riley raised its price target on Angel Studios (NYSE:ANGX) to $8 from $7 and kept a Buy rating on June 30. The firm cited higher fiscal Q2 estimates tied to paying Guild members and said Angel Studios may benefit from an improved film slate, including Young Washington’s theater debut. Angel Studios reported fiscal Q1 2026 revenue up 143% to $115.1 million.